Product Information
Name:SF 1126
Synonyms:
- N2-[1,4-Dioxo-4-[[4-(4-oxo-8-phenyl-4H-1-benzopyran-2-yl)morpholinium-4-yl]methoxy]butyl]-L-arginylglycyl-L-α-aspartyl-L-serine
- inn er salt
Brand:Biosynth
Description:SF 1126 is a synthetic small-molecule drug, which is derived from a benzotriazine-based scaffold. It functions as a phosphatidylinositol-3-kinase (PI3K) inhibitor with additional inhibition of mTOR, a serine/threonine kinase. This dual action mechanism disrupts critical signaling pathways involved in tumor growth and survival.
The compound specifically targets PI3K, a key component of the PI3K/AKT/mTOR signaling pathway, which is often hyperactivated in various cancers. By inhibiting PI3K and mTOR, SF 1126 effectively reduces phosphorylation of downstream effectors, leading to decreased cell proliferation and induced apoptosis in tumor cells.
SF 1126's applications primarily include cancer therapy, where it has been investigated for its antitumor properties in preclinical models. This compound holds promise as a therapeutic agent, particularly in malignancies exhibiting dysregulation of the PI3K/AKT/mTOR pathway. Current research explores its potential effectiveness in combination with other anticancer agents to enhance therapeutic outcomes.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:852.85 g/mol
Formula:C39H48N8O14
Purity:Min. 95%
Technical inquiry about: SF 1126
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.